MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Data-driven identification of distinct fronto-subcortical and cortical-posterior subtypes of cognitive decline in Parkinson’s disease

M. Grothe, M. Labrador-Espinosa, S. Jesús, F. Roldán Lora, M. Aguilar Barberá, P. Pastor, S. Escalante Arroyo, B. Solano Vila, A. Cots Foraster, J. Ruiz Martínez, F. Carrillo Padilla, M. Pueyo Morlans, I. González Aramburu, J. Infante Ceberio, J. Hernández Vara, O. de Fábregues-Boixar, T. Deus Fonticoba, B. Pascual-Sedano, SG. Coppadis, P. Martínez-Martín, J. Kulisevsky, D. Santos-García, P. Mir (Seville, Spain)

Meeting: 2022 International Congress

Abstract Number: 1219

Keywords: Cognitive dysfunction, Parkinson’s, Parkinsonism dementia complex(PDC)

Category: Parkinson's Disease: Cognitive functions

Objective: To use a novel data-driven approach, Subtype and Stage inference (SuStain)[1], for identifying distinct subtypes of domain-specific cognitive decline in Parkinson’s disease (PD), and study their respective risks for developing dementia.

Background: Individual trajectories of cognitive decline in PD are highly heterogeneous, but previous clustering approaches for subtyping cognition in PD showed limited success in disentangling variance related to overall severity versus domain-specific subtype of cognitive decline [2].

Method: We included 683 nondemented PD patients and 204 healthy controls from the multicentric COPPADIS study, who had standardized neurocognitive assessment with the PD-Cognitive Rating Scale (PD-CRS). Individual PD-CRS item scores were converted to age- and education-adjusted w-scores with reference to the healthy controls and then modeled with SuStain, which combines clustering with event-based modeling to disentangle cognitive subtypes together with their estimated stages of cognitive progression. Identified subtypes were characterized in terms of clinical features, regional brain atrophy on MRI (in a subset), and risk of developing dementia over 2y follow-up.

Results: SuStain found cross-validated evidence for the existence of two distinct subtypes of cognitive decline among PD patients (S1, N=194; S2, N=189), together with a third group of unimpaired patients (S0, N=300). S1 showed initial impairment in attention and working memory, followed by clock drawing and verbal fluency, whereas S2 initially showed selective impairment in clock drawing and copy performance, followed by attention deficits [figure1]. Subtypes did not differ in global cognition (MMSE), but S1 was overall more impaired in the “fronto-subcortical” PD-CRS summary score, and S2 more impaired in the “cortical-posterior” score [table1]. S1 had a higher proportion of females, but subtypes did not differ in any other clinical features. Exploratory MRI analysis showed slightly more pronounced temporal cortical atrophy in S2 [figure2], but both subtypes had similar risk of developing dementia (S0: 1%, S1: 11%, S2: 7%).

Conclusion: This large-scale data-driven analysis confirms the existence of distinct “fronto-subcortical” and “cortical-posterior” cognitive subtypes in PD, which showed similar short-term risks of developing dementia.

Fig1 SuStain

Table1 v2

Fig2 SuStain

References: [1] Young et al. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference. Nat Commun. 2018 Oct 15;9(1):4273.
[2] Dujardin et al. The spectrum of cognitive disorders in Parkinson’s disease: a data-driven approach. Mov Disord. 2013 Feb;28(2):183-9.

To cite this abstract in AMA style:

M. Grothe, M. Labrador-Espinosa, S. Jesús, F. Roldán Lora, M. Aguilar Barberá, P. Pastor, S. Escalante Arroyo, B. Solano Vila, A. Cots Foraster, J. Ruiz Martínez, F. Carrillo Padilla, M. Pueyo Morlans, I. González Aramburu, J. Infante Ceberio, J. Hernández Vara, O. de Fábregues-Boixar, T. Deus Fonticoba, B. Pascual-Sedano, SG. Coppadis, P. Martínez-Martín, J. Kulisevsky, D. Santos-García, P. Mir. Data-driven identification of distinct fronto-subcortical and cortical-posterior subtypes of cognitive decline in Parkinson’s disease [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/data-driven-identification-of-distinct-fronto-subcortical-and-cortical-posterior-subtypes-of-cognitive-decline-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/data-driven-identification-of-distinct-fronto-subcortical-and-cortical-posterior-subtypes-of-cognitive-decline-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley